Global Strategy Unveiled to Combat Maternal Hypertension
In a bold move to address a silent killer, the World Health Organization (WHO) has unveiled an ambitious global roadmap to tackle hypertensive disorders of pregnancy. Announced during the SMFM Global Congress on 8 October 2026, the strategy seeks to curb preventable maternal and newborn deaths caused by conditions such as pre-eclampsia. This initiative, spanning from 2026 to 2035, targets the heart of a problem that affects millions of women worldwide.
Hypertensive disorders in pregnancy remain a leading cause of maternal mortality and morbidity. The WHO's roadmap aims to bring together international experts and resources to accelerate medical research and broaden access to life-saving interventions. With a focus on innovation, the programme intends to deliver practical solutions that are accessible to even the most vulnerable populations.
The roadmap's launch comes at a crucial time, as healthcare systems worldwide grapple with the complexities of maternal health. According to WHO statistics, hypertensive disorders account for a significant proportion of maternal and perinatal deaths. Bridging the gap in healthcare access and improving education about these conditions are central themes of the roadmap.
Moreover, the initiative emphasises the importance of community involvement and the role of local healthcare providers in detecting and managing high blood pressure early in pregnancy. By fostering a collaborative approach, the WHO hopes to create a sustainable model that can be adapted to different regions and healthcare settings.
As the world looks forward, this roadmap represents a pivotal opportunity to make lasting change. It challenges countries to prioritise maternal health and invest in the future of women and children across the globe. The success of this initiative could set a precedent for tackling other pressing health issues with similar vigour and commitment.
